Figure 1
Five-year predicted observed survival proportions by sex and age group, selected cancers, ages 0 to 14, Canada excluding Quebec, 2013 to 2017
Data table for Figure 1
OSP (%) | 95% confidence intervals - lower limit | 95% confidence intervals - upper limit | |
---|---|---|---|
Lymphoid leukemias | |||
Male | 93.7 | 91.3 | 95.4 |
Female | 92.6 | 89.7 | 94.7 |
Age (years) | |||
0 to 4 | 94.3 | 92.0 | 96.0 |
5 to 9 | 94.8 | 91.4 | 96.9 |
10 to 14 | 87.2 | 81.1 | 91.4 |
Astrocytomas | |||
Male | 82.2 | 74.9 | 87.5 |
Female | 82.9 | 76.3 | 87.8 |
Age (years) | |||
0 to 4 | 88.8 | 81.1 | 93.5 |
5 to 9 | 79.5 | 70.6 | 86.0 |
10 to 14 | 79.0 | 69.7 | 85.8 |
Neuroblastoma and ganglioneuroblastoma | |||
Male | 85.6 | 77.6 | 90.9 |
Female | 85.4 | 77.5 | 90.7 |
Age (years) | |||
0 to 4 | 87.0 | 81.6 | 90.9 |
Notes: OSP = observed survival proportion. Quebec is excluded because cases diagnosed in Quebec from 2011 onward had not been submitted to the Canadian Cancer Registry. Results are not displayed for categories where the standard error of the point estimate exceeds 0.05. Vertical bars denote 95% confidence intervals. Source: Statistics Canada, Canadian Cancer Registry death linked file (1992 to 2017). |
Report a problem on this page
Is something not working? Is there information outdated? Can't find what you're looking for?
Please contact us and let us know how we can help you.
- Date modified: